Postoperative Analgesia Using a Perineural Catheter Versus a Single Nerve Block in Rearfoot Surgery (CATHORNOT)
A Comparative Evaluation of Postoperative Analgesia Using a Perineural Catheter Versus a Single Nerve Block in Rearfoot Surgery
Postoperative pain following hindfoot surgery is often severe and can persist for several days. It frequently leads to the use of systemic analgesics, particularly opioids, whose adverse effects are well known. Furthermore, poorly controlled postoperative pain is a recognized independent risk factor for the development of chronic pain.
Ambulatory perineural catheter techniques, already used in our department for hindfoot surgeries, allow for continuous infusion of local anesthetic. They have demonstrated their efficacy in numerous orthopedic surgeries, but data specific to hindfoot surgery remain limited. It therefore seems appropriate to evaluate whether prolonged analgesia via a perineural catheter improves postoperative pain management and promotes functional recovery.
The study is conducted as a practice evaluation audit. It relies on the collection of data from routine care, without any modification to intraoperative care. This methodology allows for an objective evaluation of the benefits of the perineural catheter compared to a single-injection popliteal sciatic block with local anesthetic, while documenting the frequency and nature of complications associated with the technique (leaks, accidental or intentional catheter removal).
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Benjamin DUMARTINET
- Numero di telefono: +33 241353637
- Email: benjamin.dumartinet@chu-angers.fr
Luoghi di studio
-
-
-
Angers, Francia
- Reclutamento
- University Hospital of Angers
-
Contatto:
- Benjamin DUMARTINET
- Numero di telefono: +33 241353637
- Email: benjamin.dumartinet@chu-angers.fr
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
University Hospital of Angers
Descrizione
Inclusion Criteria:
- Adult patients;
- Patients with an American Society of Anesthesiologists physical status (ASA score) of 1, 2, or 3;
- Patients who have undergone hindfoot surgery;
- Patients capable of completing the questionnaires.
Exclusion Criteria:
- Contraindications to regional anesthesia (known hypersensitivity to the local anesthetic, infection at the injection site, uncontrolled neurological condition);
- Emergency surgery
- Cognitive impairment;
- Uncontrolled psychiatric condition;
- Pregnancy or breastfeeding;
- Substance abuse;
- Use of neuroleptics or lithium;
- Individuals subject to legal guardianship
- Individuals deprived of liberty by judicial or administrative order
- Patients who object to the study.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Modelli osservazionali: COHORT
- Prospettive temporali: PROSPECTIVE
Numero di gruppi/coorti
Coorti e interventi
Gruppo / CoorteGruppo / Coorte |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
anestesia regionale
|
All patients are contacted by phone to assess pain during movement and at rest on each of the first 3 days after surgery, as well as their use of various pain medications regional anesthesia |
|
ambulatory perineural catheter
|
All patients are contacted by phone to assess pain during movement and at rest on each of the first 3 days after surgery, as well as their use of various pain medications Use of a perineural catheter for ambulatory analgesia |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Pain on movement using a numerical scale from 0 (no pain) to 10 (maximum pain)
Lasso di tempo: Day 1 postoperative
|
Postoperative pain on movement at Day 1. Pain intensity during movement assessed using an 11-point Numerical Rating Scale (NRS; 0 = no pain, 10 = worst possible pain) |
Day 1 postoperative
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
postoperative pain at rest using a numerical scale from 0 (no pain) to 10 (maximum pain)
Lasso di tempo: Postoperative Day 0 through Postoperative Day 3
|
to assess analgesic efficacy at rest |
Postoperative Day 0 through Postoperative Day 3
|
|
postoperative pain during mobilization using a numerical scale from 0 (no pain) to 10 (maximum pain)
Lasso di tempo: From Baseline to Day 3
|
to evaluate the analgesic efficacy during mobilization |
From Baseline to Day 3
|
|
Postoperative consumption of morphine equivalents in milligrams
Lasso di tempo: Postoperative Day 0 through Postoperative Day 3
|
Cumulative |
Postoperative Day 0 through Postoperative Day 3
|
|
Daily postoperative consumption of morphine equivalents in milligrams
Lasso di tempo: Baseline, Day 1, Day 2 and Day 3
|
Daily |
Baseline, Day 1, Day 2 and Day 3
|
|
Postoperative use of non-opioid analgesics
Lasso di tempo: Postoperative Day 0 through Postoperative Day 3
|
Cumulative |
Postoperative Day 0 through Postoperative Day 3
|
|
Daily postoperative use of non-opioid analgesics
Lasso di tempo: Baseline, Day 1, Day 2 and Day 3
|
Daily |
Baseline, Day 1, Day 2 and Day 3
|
|
French Quality of Recovery -15 score (FQoR-15 - from 0 to 150)
Lasso di tempo: Postoperative Day 0 through Postoperative Day 2
|
to assess functional recovery and postoperative rehabilitation |
Postoperative Day 0 through Postoperative Day 2
|
|
Proportion of patients experiencing at least one adverse event related to the regional anesthesia technique
Lasso di tempo: Postoperative Day 0 through Postoperative Day 3
|
Accidental or intentional removal of the catheter Leaks at the injection site or in the infusion system Bruise or local infection Falls potentially related to the residual motor block |
Postoperative Day 0 through Postoperative Day 3
|
|
proportion of patients experiencing at least one postoperative complication following hindfoot surgery
Lasso di tempo: Postoperative Day 0 through Postoperative Day 3
|
Readmission to the hospital Consultation with the attending physician for uncontrolled postoperative pain or complications related to the procedure Confirmed infection with antibiotic treatment initiated |
Postoperative Day 0 through Postoperative Day 3
|
|
length of hospital stay, calculated in whole days
Lasso di tempo: Postoperative Day 0 through Postoperative Day 3
|
Duration censored on Day 3 if the patient is still hospitalized on that date |
Postoperative Day 0 through Postoperative Day 3
|
Collaboratori e investigatori
Sponsor
Sponsor
Investigatori
Investigatori
- Investigatore principale: Benjamin DUMARTINET, University Hospital of Angers
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- 49RC26_0116
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .